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The spring forum season ended with an 
enlightening presentation by Wayne Rosenkrans 
of the Personalized Medicine Coalition (PMC). Dr. 
Rosenkrans is a Distinguished Fellow at the Center 
for Biomedical Innovation at MIT, where he works 
on health care strategy and policy issues related 
to science and medicine. He is also a member 
of the Ethics and Systems Medicine Program at 
Georgetown University. 
PMC is an organization designed to educate the 
public and policy makers, while promoting new 
ways of thinking about health care. PMC represents 
a broad spectrum of more than 200 academic, 
industry, patient, provider and payer communities, 
in an effort to advance the understanding and 
adoption of personalized medicine concepts and 
products for the benefit of patients. 
Dr. Rosenkrans addressed the impending 
intersection of declining healthcare quality vs. 
increasing healthcare costs and the tools needed 
to find the solutions. He bluntly stated that the 
current situation in healthcare is not sustainable 
and that no single part of the healthcare system 
or any single sector of industry can do it alone. 
Dr. Rosenkrans provided an overview of the 
federal agencies that play a significant role 
overseeing funding and research related to 
improving value in health care. Rosenkrans 
also described the role the Patient-Centered 
Outcomes Research Institute (PCORI), which was 
set up to as independent entity to complement 
health care reform and conduct research to offer 
information to patients and providers based on 
the best available evidence. 
Rosenkrans emphasized that value in health care 
is often expressed as the increment in clinical 
benefit achieved (health and/or quality of life 
improvement), for those receiving a particular 
service or set of services in conjunction with the 
investment required.  
He went on to define personalized healthcare as a 
model for generating meaningful segmentations 
of patient populations through appropriate 
technology, in order to increase the benefit of 
therapy. It is a proactive rather than reactive 
approach. He describes the “P” for the future or 
the characteristics of personalized health care as: 
prescriptive; precision; preventive; participatory; 
and performance. 
Rosenkrans envisions a new paradigm in 
healthcare centered on Health Information 
Technology with linkages between comparative 
effectiveness, personalized health care, and real 
world effectiveness.  
For more information on PMC visit: 
www.personalizedmedicinecoalition.org
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